Riquelme I - Search Results

1

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.

Letelier P, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC. Letelier P, et al. Among authors: riquelme i. Int J Mol Sci. 2016 May 23;17(5):791. doi: 10.3390/ijms17050791. Int J Mol Sci. 2016. PMID: 27223281 Free PMC article. Review.

2

Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.

Letelier P, Garcia P, Leal P, Ili C, Buchegger K, Riquelme I, Sandoval A, Tapia O, Roa JC. Letelier P, et al. Among authors: riquelme i. Appl Immunohistochem Mol Morphol. 2014 Aug;22(7):530-6. doi: 10.1097/PAI.0b013e3182a318a9. Appl Immunohistochem Mol Morphol. 2014. PMID: 24185122 Clinical Trial.

3

The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance.

Tapia O, Riquelme I, Leal P, Sandoval A, Aedo S, Weber H, Letelier P, Bellolio E, Villaseca M, Garcia P, Roa JC. Tapia O, et al. Among authors: riquelme i. Virchows Arch. 2014 Jul;465(1):25-33. doi: 10.1007/s00428-014-1588-4. Epub 2014 May 21. Virchows Arch. 2014. PMID: 24844205

4

Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy-naïve pT2 gallbladder adenocarcinoma patients.

Espinoza JA, García P, Bizama C, Leal JL, Riquelme I, Weber H, Macanas P, Aguayo G, Viñuela E, Roa JC, Nervi B. Espinoza JA, et al. Among authors: riquelme i. Histopathology. 2016 Apr;68(5):722-8. doi: 10.1111/his.12805. Epub 2015 Oct 21. Histopathology. 2016. PMID: 26266900

5

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.

Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Riquelme I, et al. Oncotarget. 2015 Sep 22;6(28):24750-79. doi: 10.18632/oncotarget.4990. Oncotarget. 2015. PMID: 26267324 Free PMC article. Review.

6

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice.

Weber H, Leal P, Stein S, Kunkel H, García P, Bizama C, Espinoza JA, Riquelme I, Nervi B, Araya JC, Grez M, Roa JC. Weber H, et al. Among authors: riquelme i. Oncotarget. 2015 Oct 13;6(31):31877-88. doi: 10.18632/oncotarget.5047. Oncotarget. 2015. PMID: 26397134 Free PMC article.

7

miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.

Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM, Araya JC, Roa JC. Riquelme I, et al. Cell Oncol (Dordr). 2016 Feb;39(1):23-33. doi: 10.1007/s13402-015-0247-3. Epub 2015 Oct 12. Cell Oncol (Dordr). 2016. PMID: 26458815 Free PMC article.

8

Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.

Buchegger K, Ili C, Riquelme I, Letelier P, Corvalán AH, Brebi P, Huang TH, Roa JC. Buchegger K, et al. Among authors: riquelme i. Biol Res. 2016 Jan 22;49:5. doi: 10.1186/s40659-016-0066-7. Biol Res. 2016. PMID: 26796959 Free PMC article.

9

Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.

Riquelme I, Letelier P, Riffo-Campos AL, Brebi P, Roa JC. Riquelme I, et al. Int J Mol Sci. 2016 Mar 22;17(3):424. doi: 10.3390/ijms17030424. Int J Mol Sci. 2016. PMID: 27011182 Free PMC article. Review.

10

The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.

Riquelme I, Tapia O, Espinoza JA, Leal P, Buchegger K, Sandoval A, Bizama C, Araya JC, Peek RM, Roa JC. Riquelme I, et al. Pathol Oncol Res. 2016 Oct;22(4):797-805. doi: 10.1007/s12253-016-0066-5. Epub 2016 May 7. Pathol Oncol Res. 2016. PMID: 27156070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters